Canaccord Genuity Initiates Coverage On Claritev with Buy Rating, Announces Price Target of $32

Benzinga Newsdesk www.benzinga.com Neutral 63.2%

Neg 0% Neu 63.2% Pos 0%

Canaccord Genuity analyst Richard Close initiates coverage on Claritev (NYSE:CTEV) with a Buy rating and announces Price Target of $32.